FutureChem Enters India With Alzheimer's Diagnostic Drug via Shrishti Deal
1d agoen
Source
Seoul Economic DailyFutureChem Enters India With Alzheimer's Diagnostic Drug via Shrishti Dealsedaily.comFutureChem signed an exclusive supply and distribution deal with India's Shrishti for its Alzheimer's diagnostic drug Alzavue, earning a 2% royalty on net sales over a 15-year term.
You might also wanna read
Unicamp analysis confirms Paraguayan weight-loss pens contain tirzepatide, the active ingredient in Mounjaro
An independent analysis by Unicamp researchers, commissioned by Folha, found that weight-loss pens manufactured in Paraguay and sold as vers

India’s Generic Pharma Industry Is Sitting on a Formulation Data Time Bomb
ChemCopilot·6d ago
Sarvam raises $300M Series B at $1.5B valuation led by HCLTech and Bessemer
Sarvam, India's full-stack sovereign AI company, announced a $300 million Series B funding round led by HCLTech and Bessemer Venture Partner

HCLTech signs $1.1 billion AI services deal with Fortune Global 50 European company
Indian IT company HCLTech has secured a $1.1 billion contract with an unnamed Fortune Global 50 European firm to deploy AI services and mana
Sarvam raises $234M at $1.5B valuation, becomes India's newest AI unicorn with HCLTech leading the round
Sarvam, a Bengaluru-based AI startup, has raised $234 million at a $1.5 billion valuation, making it India's newest AI unicorn. The funding
L&T Vyoma partners Fortanix to deliver sovereign AI security solutions in India
ET Pharma·9h ago
L&T Vyoma partners Fortanix to deliver sovereign AI security solutions in India
ET Pharma·9h ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.